Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2026-01 · 24 (1)
DOI: 10.6004/jnccn.2026.0001 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-01. Verfasst von Shaji K Kumar und 36 weiteren Autor:innen. Beteiligte Einrichtung: 1Mayo Clinic Comprehensive Cancer Center. Hauptthemen laut MEDLINE: Multiple Myeloma, Medical Oncology. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 398 Literaturangaben. Gefördert von: CSRD VA.
Abstract (Originalsprache)
The treatment landscape for multiple myeloma (MM) is evolving rapidly and includes several new options. The management must be tailored to the individual. The NCCN Guidelines for MM provide a framework to base decisions regarding diagnosis, workup, treatment, and follow-up of both newly diagnosed and previously treated relapsed/refractory MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to newly diagnosed MM (NDMM).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Mayo Clinic Comprehensive Cancer Center.
- 2University of Wisconsin Carbone Cancer Center.
- 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- 4UT Southwestern Simmons Comprehensive Cancer Center.
- 5Vanderbilt-Ingram Cancer Center.
- 6Moffitt Cancer Center.
Förderung
- CSRD VA
Zitieren
APA
Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L. D., Baljevic, M., Baz, R., Campagnaro, E., Costello, C., D'Angelo, C., Derman, B., Devarakonda, S., Elsedawy, N., Godara, A., Godby, K., Hillengass, J., Holmberg, L., Htut, M., Huff, C. A., Hultcrantz, M., …, & Kumar, R. (2026). Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 24(1). https://doi.org/10.6004/jnccn.2026.0001
Vancouver
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, et al. Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2026;24(1). doi:10.6004/jnccn.2026.0001
BibTeX
@article{Kumar2026,
author = {Kumar, Shaji K and Callander, Natalie S and Adekola, Kehinde and Anderson, Larry D and Baljevic, Muhamed and Baz, Rachid and Campagnaro, Erica and Costello, Caitlin and D'Angelo, Christopher and Derman, Benjamin and Devarakonda, Srinivas and Elsedawy, Noura and Godara, Amandeep and Godby, Kelly and Hillengass, Jens and Holmberg, Leona and Htut, Myo and Huff, Carol Ann and Hultcrantz, Malin and Kang, Yubin and Larson, Sarah and Lee, Hans C and Liedtke, Michaela and Martin, Thomas and Omel, James and Robinson, Timothy J and Rosenberg, Aaron and Sarosiek, Shayna R and Schroeder, Mark A and Sherbenou, Daniel and Suvannasankha, Attaya and Valent, Jason and Varshavsky-Yanovsky, Asya Nina and Vogl, Dan and Ye, Jing Christine and Kovach, Emily and Kumar, Rashmi},
title = {Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {1},
doi = {10.6004/jnccn.2026.0001}
}
EUVIMED